115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12935)
  10. Department of Pathology and Laboratory Medicine (12608)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A single-cell atlas of classical mantle cell lymphoma reveals paired tumor-immune malignant states correlating with prognosis
    Meeting Abstract

    Marouf, A.; Mitra, S.; Isgor, I.; Joseph, A.; Rahman, J.; Lin, Y. H.; Takizawa, M.; Chaligne, R.; Sethi, S.; Dogan, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Treatment patterns and outcomes following progression of disease post-CAR-T therapy in relapsed or refractory mantle cell lymphoma: A multicenter analysis
    Meeting Abstract

    Epstein-Peterson, Z. D.; Lionel, A. C.; Joseph, A.; Drill, E.; Atallah-Yunes, S. A.; Brooks, T. R.; Chong, E. A.; Chong, E. R.; Dela Cruz, J.; Frank, M. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • TP53 alterations confer increased risk of leukemic transformation and worse survival as compared to high molecular risk mutations in patients with myeloproliferative neoplasms
    Meeting Abstract

    Handa, S.; Riazat-Kesh, Y. J. R. A.; Butterfield, R. J.; Sivakumar, G.; Venugopal, S.; McGovern, E.; Feld, J.; Tremblay, D.; Elghaity-Beckley, S.; Kremyanskaya, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • The association of prior acquired or heritage language exposures with medical students' Spanish language proficiency
    Meeting Abstract

    Diamond, L. C.; Figueroa, J. A. A.; Gregorich, S.; Karliner, L. S.; Pérez-Cordón, C.; González, J.; Ortega, P.
    Journal of General Internal Medicine (2024)

    Fulltext@MSK | Save
  • The effect of biosimilar entry on biologic drug prices in Medicare part B
    Meeting Abstract

    Winn, A.; Abdelaziz, A.; Dusetzina, S. B.; Mitchell, A. P.
    Value in Health (2024)

    Fulltext@MSK | Save
  • Cost-effectiveness (CE) of a multi-cancer early detection (MCED) test varies with population cancer risk
    Meeting Abstract

    Raoof, S.; Kansal, A.; Tafazzoli, A.; Ye, W.; Zou, D.; Fendrick, A. M.
    Value in Health (2024)

    Fulltext@MSK | Save
  • Duration of residence and obesity prevalence among us immigrant adults; Data from the 2019, 2021, and 2022 National Health Interview Survey
    Meeting Abstract

    Claros, M.; Fleishman, A.; Bui, L.; McCarthy, E.; Wee, C. C.
    Journal of General Internal Medicine (2024)

    Fulltext@MSK | Save
  • Matching-adjusted indirect comparison (MAIC) of safety outcomes with MET tyrosine kinase inhibitors (TKIs) in patients with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Taylor, K.; Veillon, R.; Griesinger, F.; Reinmuth, N.; Ghori, V.; Vioix, H.; Clark, A.; Paik, P.
    Value in Health (2024)

    Fulltext@MSK | Save
  • Updated results and longer follow-up from the AUGMENT-101 phase 2 study of revumenib in all patients with relapsed or refractory (R/R) KMT2Ar acute leukemia
    Meeting Abstract

    Aldoss, I.; Issa, G. C.; Blachly, J. S.; Thirman, M. J.; Mannis, G. N.; Arellano, M. L.; DiPersio, J. F.; Traer, E.; Zwaan, C. M.; Shukla, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Gilteritinib results in higher remission and transplant rates than midostaurin but does not increase the post-induction mutational MRD negative rate: Results of the phase 2 randomized PrECOG 0905 study in newly diagnosed FLT3 mutated AML
    Meeting Abstract

    Luger, S.; Chen, L.; Pratz, K. W.; Loghavi, S.; Perl, A. E.; Altman, J. K.; Redner, R. L.; Fathi, A. T.; Qasrawi, A.; Asch, A. S.; more...
    Blood (2024)

    Fulltext@MSK | Save